+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

protosappanin A

BP3329
102036-28-2
98%
Biopurify
Protosappanin A has anti-oxidative/nitrative activities on brain immune and neuroinflammation through regulation of CD14/TLR4-dependent IKK/IκB/NF-κB inflammation signal pathway; it exerts anti-neuroinflammatory effect by inhibiting JAK2-STAT3 pathway in lipopolysaccharide-induced BV2 microglia. Protosappanin A induces immunosuppression of rats heart transplantation targeting T cells in grafts via NF-kappaB pathway. Protosappanin A and protosappanin B have antimicrobial activity, they show both alone activities and resistance reversal effects of amikacin and gentamicin against MRSA. Protosappanin A shows strong effect against HIV-1 IN with an IC50 value of 12.6 uM. Protosappanin A is a member of catechols. It has a role as a metabolite.
Catalog No Package Original Price Price Inventory Quantity Operating
BP3329-10mg 10mg
BP3329-20mg 20mg
BP3329-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

BCL2 STAT3 TOP1 RELA TNF NOS2 PTGS2 CASP3 IL6 ICAM1 VCAM1 BAX
STAT3 RELA TNF NOS2 PTGS2 IL6 ICAM1 JAK2
BCL2 STAT3 RORC RELA TNF NOS2 PTGS2 IL6 JAK2 IFNG IL17A
BCL2 STAT3 RELA TNF NOS2 PTGS2 CASP3 IL6 ICAM1 BAX

protosappanin A Related Products

Product drug property prediction parameters

  • 86.9900

  • 1.5412

  • 1.5153

  • .2631

  • 3.4130

  • 8.9808

  • Low

  • 81.5810

  • 2.6354

  • No

  • No

  • No

  • No

  • Yes

  • Yes

  • 0.6

  • Yes

  • Yes

  • Yes

  • Yes